Physician profile
Gail D Brown
NPI 1063444115
$2,479.36
in general payments reported to CMS, 2019-2025
24 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $142 · 2021: $28.05 · 2022: $1,525 · 2023: $252 · 2024: $113 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,163.48 | 2022 | |
| Abbvie INC. | $273.94 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $105.63 | 2022-2024 | |
| Astellas Pharma US INC | $96.47 | 2023-2025 | Veozah |
| Biogen, INC. | $93.20 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $83.69 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $74.53 | 2019-2025 | Acessa Provu System |
| Myovant Sciences INC. | $69.05 | 2022 | |
| Sumitomo Pharma America, INC. | $65.81 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $61.39 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $56.22 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.03 | 2019-2025 | |
| Scynexis, INC. | $47.85 | 2022 | |
| Pfizer INC. | $42.40 | 2020-2023 | |
| Duchesnay USA Incorporated | $37.55 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $23.07 | 2023-2024 | |
| Organon LLC | $21.45 | 2025 | Nexplanon |
| Minerva Surgical, INC | $20.55 | 2022 | |
| Amgen INC. | $20.45 | 2020 | |
| Daiichi Sankyo INC. | $15.38 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.96 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.37 | 2023 | Seglentis |
| Lupin INC. | $12.71 | 2020 | |
| Asensus Surgical, INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.